Keli An

491 total citations
11 papers, 400 citations indexed

About

Keli An is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Keli An has authored 11 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Biomedical Engineering and 2 papers in Oncology. Recurrent topics in Keli An's work include RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Immunotherapy and Immune Responses (2 papers). Keli An is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Immunotherapy and Immune Responses (2 papers). Keli An collaborates with scholars based in China, Taiwan and Germany. Keli An's co-authors include Feng Xu, Penghui Zhang, Xili Duan, Hao Xu, Fei Li, Weihong Tan, Yuchao Zhang, Yuanbo Jia, Songmei Geng and Hao Liu and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Keli An

10 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keli An China 5 217 131 83 69 41 11 400
Renato M. S. Cardoso Portugal 11 312 1.4× 77 0.6× 98 1.2× 37 0.5× 24 0.6× 17 498
Zi-Xian Liao Taiwan 9 279 1.3× 158 1.2× 201 2.4× 58 0.8× 37 0.9× 14 531
Sanja Dimitrijevic Serbia 9 142 0.7× 300 2.3× 199 2.4× 81 1.2× 128 3.1× 14 596
Neelima Gupta India 8 193 0.9× 285 2.2× 237 2.9× 131 1.9× 37 0.9× 11 544
Madumali Kalubowilage United States 9 275 1.3× 80 0.6× 63 0.8× 32 0.5× 12 0.3× 13 388
Xumei Ouyang China 10 206 0.9× 190 1.5× 104 1.3× 65 0.9× 51 1.2× 13 449
Zhe Zhi China 10 147 0.7× 179 1.4× 101 1.2× 107 1.6× 41 1.0× 12 392
Prajakta Tambe India 10 142 0.7× 136 1.0× 189 2.3× 77 1.1× 20 0.5× 18 377
Yasser Heakal United States 7 246 1.1× 150 1.1× 100 1.2× 83 1.2× 66 1.6× 8 449
Zewen Wei China 12 172 0.8× 220 1.7× 29 0.3× 24 0.3× 66 1.6× 21 425

Countries citing papers authored by Keli An

Since Specialization
Citations

This map shows the geographic impact of Keli An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keli An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keli An more than expected).

Fields of papers citing papers by Keli An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keli An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keli An. The network helps show where Keli An may publish in the future.

Co-authorship network of co-authors of Keli An

This figure shows the co-authorship network connecting the top 25 collaborators of Keli An. A scholar is included among the top collaborators of Keli An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keli An. Keli An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, Chao, Yani Wang, Shiqi Jiang, et al.. (2024). Programmable Circular Multispecific Aptamer-Drug Engager to Broadly Boost Antitumor Immunity. Journal of the American Chemical Society. 146(50). 34311–34323. 3 indexed citations
2.
Jiang, Shiqi, Zhenlin Ouyang, Jiaxuan He, et al.. (2024). Programmable Circular Multivalent Nanobody‐Targeting Chimeras (mNbTACs) for Multireceptor‐Mediated Protein Degradation and Targeted Drug Delivery. Angewandte Chemie International Edition. 63(52). e202407986–e202407986. 3 indexed citations
3.
Li, Yan, et al.. (2024). Stimuli-Responsive mRNA Vaccines to Induce Robust CD8+ T Cell Response via ROS-Mediated Innate Immunity Boosting. Journal of the American Chemical Society. 146(28). 19218–19228. 22 indexed citations
5.
Zhang, Yanru, Qi Lü, Keli An, et al.. (2023). Uncertainties of Climate Change on Suitable Habitat of Calligonum mongolicum Turcz. (Polygonaceae) in Desert Areas of Central Asia. Forests. 14(5). 1053–1053. 2 indexed citations
6.
Jia, Yuanbo, Jiahui Hu, Keli An, et al.. (2023). Hydrogel dressing integrating FAK inhibition and ROS scavenging for mechano-chemical treatment of atopic dermatitis. Nature Communications. 14(1). 2478–2478. 77 indexed citations
7.
An, Keli, Yuchao Zhang, Yan Li, et al.. (2023). Stimuli‐Responsive PROTACs for Controlled Protein Degradation. Angewandte Chemie. 135(39). 4 indexed citations
8.
An, Keli, Yuchao Zhang, Yan Li, et al.. (2023). Stimuli‐Responsive PROTACs for Controlled Protein Degradation. Angewandte Chemie International Edition. 62(39). e202306824–e202306824. 49 indexed citations
9.
Li, Zhijie, et al.. (2023). Thermo-Chemical Resistance to Combination Therapy of Glioma Depends on Cellular Energy Level. ACS Applied Materials & Interfaces. 15(33). 39053–39063. 3 indexed citations
10.
Zhang, Penghui, Di Gao, Keli An, et al.. (2020). A programmable polymer library that enables the construction of stimuli-responsive nanocarriers containing logic gates. Nature Chemistry. 12(4). 381–390. 150 indexed citations
11.
Zhang, Penghui, Keli An, Xili Duan, et al.. (2018). Recent advances in siRNA delivery for cancer therapy using smart nanocarriers. Drug Discovery Today. 23(4). 900–911. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026